[EN] NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES [FR] NOUVEAUX DÉRIVÉS ARYLALCÉNYLPROPARGYLAMINE FAISANT PREUVE D'ACTION NEUROPROTECTRICE POUR LE TRAITEMENT DES MALADIES NEURODÉGÉNÉRATIVES
[EN] NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES<br/>[FR] NOUVEAUX DÉRIVÉS ARYLALCÉNYLPROPARGYLAMINE FAISANT PREUVE D'ACTION NEUROPROTECTRICE POUR LE TRAITEMENT DES MALADIES NEURODÉGÉNÉRATIVES
申请人:SEMMELWEIS EGYETEM
公开号:WO2015087094A1
公开(公告)日:2015-06-18
The invention relates to novel arylalkenylpropargylamine derivatives of general formula (I) or enantiomers or diastereomers thereof or salts, optionally pharmaceutically acceptable salts, or solvates of any of these. The compounds can be used in treating or preventing a disease or condition in a mammal related to monoamine oxidase dysfunction, especially in neurodegenerative diseases, e.g. Parkinson's disease, Alzheimer's disease or Huntington's disease.
A direct and efficient method was developed for the preparation of a variety of substituted acetophenone derivatives from readily available arene precursors and acid chlorides. This method has significant generality and affords access to substitution patterns on aryl rings not directly achievable by Friedel-Crafts chemistry. [reaction: see text].